Autolus Therapeutics (AUTL) Total Liabilities (2017 - 2025)

Autolus Therapeutics (AUTL) has 9 years of Total Liabilities data on file, last reported at $410.9 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 15.63% year-over-year to $410.9 million; the trailing twelve-month figure through Dec 2025 stood at $410.9 million (up 15.63% YoY), and the FY2025 full-year result was $410.9 million, up 15.63% from the prior year.
• Total Liabilities for Q4 2025 stood at $410.9 million, up from $396.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $410.9 million in Q4 2025 and bottomed at $47.0 million in Q2 2021.
• The 5-year median for Total Liabilities is $223.6 million (2023), against an average of $227.0 million.
• The widest annual swing landed in 2021, when Total Liabilities slumped 35.33%; it then jumped 122.87% in 2023.
• A 5-year view of Total Liabilities shows it stood at $92.2 million in 2021, then jumped by 107.72% to $191.6 million in 2022, then soared by 37.74% to $263.9 million in 2023, then surged by 34.67% to $355.4 million in 2024, then advanced by 15.63% to $410.9 million in 2025.
• The last three Total Liabilities figures came in at $410.9 million (Q4 2025), $396.5 million (Q3 2025), and $374.5 million (Q2 2025), per Business Quant data.

Peer Comparison